rs371876622
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_005902.4(SMAD3):c.394A>G(p.Thr132Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000142 in 1,614,048 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T132T) has been classified as Likely benign.
Frequency
Consequence
NM_005902.4 missense
Scores
Clinical Significance
Conservation
Publications
- aneurysm-osteoarthritis syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMAD3 | NM_005902.4 | c.394A>G | p.Thr132Ala | missense_variant | Exon 2 of 9 | ENST00000327367.9 | NP_005893.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMAD3 | ENST00000327367.9 | c.394A>G | p.Thr132Ala | missense_variant | Exon 2 of 9 | 1 | NM_005902.4 | ENSP00000332973.4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152210Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251402 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461838Hom.: 0 Cov.: 39 AF XY: 0.0000165 AC XY: 12AN XY: 727220 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152210Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74354 show subpopulations
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Uncertain:3
The p.T132A variant (also known as c.394A>G), located in coding exon 2 of the SMAD3 gene, results from an A to G substitution at nucleotide position 394. The threonine at codon 132 is replaced by alanine, an amino acid with similar properties. This variant was reported in a thoracic aortic aneurysm and dissection (TAAD) cohort; however, clinical details were limited (Overwater E et al. Hum Mutat, 2018 09;39:1173-1192). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
This missense variant replaces threonine with alanine at codon 132 of the SMAD3 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with aortic aneurysm and in another two unrelated individuals affected with aortic dilation (PMID: 29907982, DOI: 10.22541/au.158739953.31329162). This variant has been identified in 5/282776 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 132 of the SMAD3 protein (p.Thr132Ala). This variant is present in population databases (rs371876622, gnomAD 0.004%). This missense change has been observed in individual(s) with aortic aneurysm (PMID: 29907982). ClinVar contains an entry for this variant (Variation ID: 213803). Invitae Evidence Modeling incorporating data from in vitro experimental studies (internal data) indicates that this missense variant is not expected to disrupt SMAD3 function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:3
- -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29907982) -
- -
Aneurysm-osteoarthritis syndrome Uncertain:2Other:1
Variant interpretted as Uncertain significance and reported on 08/23/2018 by GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
- -
This missense variant replaces threonine with alanine at codon 132 of the SMAD3 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with aortic aneurysm and in another two unrelated individuals affected with aortic dilation (PMID: 29907982, DOI: 10.22541/au.158739953.31329162). This variant has been identified in 5/282776 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at